Home > News > Rexahn, university partner for drug development
March 4th, 2006
Rexahn, university partner for drug development
Abstract:
The University of Maryland has teamed with Rexahn Pharmaceuticals to improve the company's drugs that treat cancer and central nervous system disorders. Researchers from the university's Center for Nanomedicine and Cellular Delivery in Baltimore will work with Rockville-based Rexahn to find new ways of applying nanotechnology research to make more effective drugs.
Source:
ACBJ
Bookmark:
| Related Links |
Center for Nanomedicine and Cellular Delivery
| Related News Press |
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025
Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
Next-generation quantum communication October 3rd, 2025
"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||